Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Sebivo, Tyzeka, Telbivudine (LdT) (LDT600)
print preview
bookmark
share with colleague
General Information
Company
Idenix Pharmaceuticals Inc.
Description
Nucleoside analog
Molecular Target
Viral polymerase
Mechanism of Action
DNA polymerase inhibitor
Latest Stage of Development
Marketed
Indication
Hepatitis B virus (HBV)
Partner
Novartis AG
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy